LTFS
BBH icon

Ladenburg Thalmann Financial Services’s VanEck Biotech ETF BBH Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio BBH Stock Details BBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$151K Sell
1,081
-122
-10% -$16K ﹤0.01% 2719
2019
Q3 		$141K Sell
1,203
-35
-3% -$4.35K ﹤0.01% 2702
2019
Q2 		$160K Hold
1,238
– – ﹤0.01% 2623
2019
Q1 		$160K Buy
1,238
+292
+31% +$36.9K ﹤0.01% 2564
2018
Q4 		$104K Sell
946
-395
-29% -$47.7K ﹤0.01% 2723
2018
Q3 		$183K Sell
1,341
-783
-37% -$102K ﹤0.01% 2375
2018
Q2 		$256K Hold
2,124
– – ﹤0.01% 2039
2018
Q1 		$256K Buy
2,124
+86
+4% +$10.8K ﹤0.01% 2039
2017
Q4 		$253K Sell
2,038
-2,779
-58% -$355K ﹤0.01% 2040
2017
Q3 		$645K Buy
4,817
+298
+7% +$38.8K 0.01% 1280
2017
Q2 		$568K Buy
4,519
+1,366
+43% +$165K 0.01% 1307
2017
Q1 		$376K Sell
3,153
-1,757
-36% -$205K ﹤0.01% 1479
2016
Q4 		$528K Sell
4,910
-974
-17% -$106K 0.01% 1214
2016
Q3 		$679K Sell
5,884
-2,270
-28% -$259K 0.01% 1014
2016
Q2 		$834K Buy
8,154
+1,495
+22% +$159K 0.01% 841
2016
Q1 		$691K Sell
6,659
-21,014
-76% -$2.19M 0.01% 860
2015
Q4 		$3.51M Buy
27,673
+2,772
+11% +$340K 0.07% 268
2015
Q3 		$2.85M Buy
24,901
+331
+1% +$43.8K 0.06% 303
2015
Q2 		$3.31M Sell
24,570
-1,760
-7% -$234K 0.06% 312
2015
Q1 		$3.41M Sell
26,330
-1,599
-6% -$201K 0.07% 290
2014
Q4 		$3.22M Buy
27,929
+3,600
+15% +$406K 0.07% 249
2014
Q3 		$2.58M Sell
24,329
-785
-3% -$79.4K 0.07% 234
2014
Q2 		$2.4M Buy
25,114
+10,854
+76% +$973K 0.07% 250
2014
Q1 		$1.3M Buy
14,260
+1,873
+15% +$182K 0.04% 379
2013
Q4 		$1.1M Sell
12,387
-993
-7% -$83K 0.03% 418
2013
Q3 		$1.11M Buy
13,380
+12,580
+1,573% +$988K 0.04% 374
2013
Q2 		$55K Buy
+800
New +$55.7K ﹤0.01% 1676

Other funds holding BBH

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
MJRIC
Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
BRM
Boston Research & Management Manchester, Massachusetts $421M AUM 16.18% 1-Year Est. Return

Ladenburg Thalmann Financial Services's BBH Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services reduced its VanEck Biotech ETF (BBH) stake by 10% in Q4 2019, selling an estimated $16K and leaving 1,081 shares worth $151K. The position accounts for ﹤0.01% of the portfolio, ranked #2719.

Ladenburg Thalmann Financial Services first reported a position in BBH in Q2 2013 and has held it in 27 quarters since. The position peaked at $3.51M in Q4 2015. 87 funds tracked by Wall St. Rank hold BBH as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 1,081 shares of VanEck Biotech ETF worth $151K as of Q4 2019.
  • Ladenburg Thalmann Financial Services sold 122 VanEck Biotech ETF shares in Q4 2019, an estimated $16K.
  • VanEck Biotech ETF made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #2719 holding.
  • Ladenburg Thalmann Financial Services first reported a position in VanEck Biotech ETF in Q2 2013 and has held it in 27 quarters since.
  • Ladenburg Thalmann Financial Services's VanEck Biotech ETF position peaked at $3.51M in Q4 2015.
  • 87 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.